MDP — Medcamp SA Income Statement
0.000.00%
- PLN20.92m
- PLN18.33m
- 19
- 17
- 64
- 21
Annual income statement for Medcamp SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | PAS | PAS | PAS | PAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0.01 | 0 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | -0.003 | 0.01 | — | -0.008 | -0.002 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1.78 | 0.686 | 1.49 | 3.21 | 0.183 |
Operating Profit | -1.78 | -0.676 | -1.49 | -3.21 | -0.183 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5.16 | -2.33 | -6.52 | -7.52 | 0.807 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.87 | -2.14 | -5.53 | -8.68 | 1.21 |
Net Income Before Extraordinary Items | |||||
Net Income | 3.87 | -2.14 | -5.53 | -8.68 | 1.21 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.87 | -2.14 | -5.53 | -8.68 | 1.21 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.148 | -0.082 | -0.212 | -0.332 | 0.046 |
Dividends per Share |